Read a short story of One-carbon Therapeutics achievements so far in Nature Biopharma Dealmakers (https://www.nature.com/articles/d43747-023-00079-z). We are working hard to bring our novel inhibitor into the clinic.
One-carbon therapeutics AB management at ESMO to discuss the ODIN clinical phase 1/2 trial with potential clinical sites across Europe
One-carbon therapeutics AB is discussing the ODIN trial with several
